Marlies Janßen

Director/Board Member at NSI N.V.

53 year

Health Technology

Finance

Profile

Marlies Janßen is currently the Co-Managing Director at Fortuna Herstellung GmbH.
She also holds positions as a Member-Supervisory Board at NSI NV and Erasmus Q-Intelligence BV.
Previously, Ms. Janßen served as the Managing Director at cas central compounding Baden-Württemberg GmbH.

Marlies Janßen active positions

Companies	Position	Start
NSI N.V.	Director/Board Member	27/02/2024
Fortuna Herstellung GmbH Fortuna Herstellung GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Chief Executive Officer	-
Erasmus Q-Intelligence BV	Director/Board Member	-

All active positions of Marlies Janßen

Former positions of Marlies Janßen

Companies	Position	End
cas central compounding Baden-Württemberg GmbH cas central compounding Baden-Württemberg GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical preparation services	Chief Executive Officer	-

See the detail of Marlies Janßen's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Marlies Janßen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
NSI NV NSI NV Real Estate Investment TrustsFinance Operates as a commercial real estate investment company with a focus on office buildings	Finance
Fortuna Herstellung GmbH Fortuna Herstellung GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
cas central compounding Baden-Württemberg GmbH cas central compounding Baden-Württemberg GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical preparation services	Health Technology
Erasmus Q-Intelligence BV